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Abstract
Background—In a recent study, high maternal periconceptional intake of vitamin E was found 
to be associated with risk of congenital heart defects (CHDs). To explore this association further, 
we investigated the association between total daily vitamin E intake and selected birth defects.
Methods—We analyzed data from 4,525 controls and 8,665 cases from the 1997–2005 National 
Birth Defects Prevention Study. We categorized estimated periconceptional energy-adjusted total 
daily vitamin E intake from diet and supplements into quartiles (referent, lowest quartile). 
Associations between quartiles of energy-adjusted vitamin E intake and selected birth defects were 
adjusted for demographic, lifestyle, and nutritional factors.
Results—We observed a statistically significant association with the third quartile of vitamin E 
intake (OR 1.17; 95% CI 1.01 – 1.35) and all CHDs combined. Among CHD sub-types, we 
observed associations with left ventricular outflow tract obstruction defects, and its sub-type, 
coarctation of the aorta and the third quartile of vitamin E intake. Among defects other than 
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CHDs, we observed associations between anorectal atresia and the third quartile of vitamin E 
intake (OR 1.66; 95% CI 1.01 – 2.72) and hypospadias and the fourth quartile of vitamin E intake 
(OR 1.42; 95% CI 1.09 – 1.87).
Conclusions—Selected quartiles of energy-adjusted estimated total daily vitamin E intake were 
associated with selected birth defects. However, because these few associations did not exhibit 
exposure-response patterns consistent with increasing risk associated with increasing intake of 
vitamin E, further studies are warranted to corroborate our findings.
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INTRODUCTION
Vitamin E (tocopherol) is an essential, lipid soluble antioxidant that exists in eight chemical 
forms; alpha-tocopherol is the only form that is recognized to meet human requirements. 
Dietary sources of vitamin E include nuts, seeds, fats/oils, meats, green leafy vegetables and 
fortified cereals. The recommended dietary allowance for vitamin E among women 14 years 
of age and older is 15 mg/day; the tolerable upper intake levels is 800 mg/day for women 
14–18 years old and 1,000 mg/day for women 19 years of age or older (Institute of Medicine 
Food and Nutrition Board, 2000). Because of its antioxidant properties and roles in anti-
inflammatory processes and immune enhancement (Institute of Medicine Food and Nutrition 
Board, 2000), vitamin E has been hypothesized to protect against adverse pregnancy 
outcomes such as preeclampsia and spontaneous preterm delivery (Bartfai and others, 2012; 
Hauth and others, 2010; Rumbold and Crowther, 2005; Rumbold and others, 2006; Villar 
and others, 2009), as well as against morbidity and mortality in very low birth weight or 
preterm infants (Brion and others, 2003). Concern about the safety of excessive vitamin E 
intake has focused on its potential for hemorrhagic effects (Institute of Medicine Food and 
Nutrition Board, 2000).
Animal data indicate that vitamin E is necessary for embryonic development (Miller and 
others, 2012) and might have a role in mediating the embryotoxic effects of alcohol and 
diabetes (Siman and Eriksson, 1997; Wentzel and others, 2006). There are four previously 
published epidemiologic studies exploring the association between maternal vitamin E 
intake and birth defects in the offspring (Boskovic and others, 2005; Smedts and others, 
2009; The and others, 2007; Yang and others, 2008). In the first publication, using data from 
the Motherisk Program, Boskovic and colleagues compared pregnant women exposed to 
high doses (≥ 400 IU/day [363 mg/day]) of vitamin E during the first trimester of pregnancy 
with unexposed pregnant women and reported no association when looking at all major 
malformations combined (Boskovic and others, 2005). In the second publication, The and 
colleagues conducted an exploratory analysis of risk factors for biliary atresia in the 
National Birth Defects Prevention Study (NBDPS), and reported an increased risk of biliary 
atresia of borderline significance associated with low daily vitamin E intake (<3.9 mg per 
1,000 calories) (adjusted odds ratio [OR] 2.02; 95% confidence interval [CI] 0.95 – 4.31) 
(The and others, 2007). The third publication was an exploratory analysis of nutritional risk 
factors for congenital diaphragmatic hernia in the NBDPS, and reported a borderline 
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protective effect of dietary intake of vitamin E among vitamin supplement users (OR 0.6; 
95% CI 0.3 – 1.1) (Yang and others, 2008). In the fourth publication, an analysis of the 
Dutch HAVEN study (a Dutch acronym for Heart Defects Vascular Status, Genetic Factors 
and Nutrition) (Smedts and others, 2009), the authors reported an increased risk for CHDs 
(OR 1.6; 95% CI 1.03 – 2.6) associated with dietary vitamin E intake in the fourth quartile 
(14.9 – 33.8 mg/day) compared to the first quartile (4.0 – 10.6 mg/day). In a small subgroup 
of mothers who took supplements containing vitamin E (12.5% of the study population), 
strong, yet imprecise associations were reported between the third (12.6 – < 14.9 mg/day) 
and fourth highest quartiles of vitamin E intake from foods and CHDs (third quartile: OR 
9.1; 95% CI 2.0 – 41.4; fourth quartile: OR 4.8; 95% CI 1.1 – 20.2). Among mothers who 
did not take any supplements or who took supplements containing folic acid, there was no 
association between CHDs and dietary vitamin E intake (Smedts and others, 2009).
Given this noteworthy and concerning result from the Dutch HAVEN study, and the 
inconsistency of this result with a prior-held belief that intake of antioxidants such as 
vitamin E would be beneficial, rather than harmful during pregnancy, we investigated the 
relation between total maternal vitamin E intake from diet and supplements and birth defects 
using data from the NBDPS.
METHODS
Study Population
The NBDPS is an ongoing, population-based case-control study comprising data collected 
by 10 birth defects surveillance systems in the United States (Cogswell and others, 2009; 
Yoon and others, 2001). Cases include live-born infants (all sites), stillbirths ≥20 weeks 
gestation (all sites except NJ, and NY before the year 2000), and elective terminations ≥20 
weeks gestation (all sites except MA and NJ, and NY before the year 2000). Cases with 
major chromosomal abnormalities or single-gene disorders are excluded (Rasmussen and 
others, 2003). Live-born control infants without major birth defects are randomly selected 
either from birth certificates or birth hospital records (Cogswell and others, 2009). The 
NBDPS was approved by the institutional review boards of CDC and the participating study 
centers.
Clinical Review and Classification of Birth Defects
Information on case infants derived from each participating state’s birth defects surveillance 
system was reviewed by clinical experts. According to NBDPS criteria, cases with a single 
or multiple birth defect affecting only one major organ system were classified as having an 
isolated defect (Botto and others, 2007; Rasmussen and others, 2003). For the current 
analysis only isolated cases were included; cases with birth defects in multiple organ 
systems were excluded to ensure greater homogeneity within outcome groups. Because of 
the previously published findings for biliary atresia (The and others, 2007) and 
diaphragmatic hernia (Yang and others, 2008) these two birth defects were excluded from 
the current analyses. For case infants with a CHD, an additional layer of classification was 
employed to denote “simple” cases as anatomically discrete or having a well-recognized 
single malformation (e.g., hypoplastic left heart syndrome or tetralogy of Fallot) (Botto and 
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others, 2007; Rasmussen and others, 2003) For CHDs, analyses were restricted to simple, 
isolated CHDs. Results are shown for birth defects with at least 50 isolated cases to ensure 
the reporting of stable effect estimates.
Inclusion Criteria
Mothers of singleton, isolated case and control infants delivered on or after October 1, 1997 
who had an estimated date of delivery on or before December 31, 2005 were eligible for this 
study (n=6,594 controls; n=12,958 cases). We excluded mothers with: self-reported pre-
existing diabetes (type I or type II) or missing information on diabetes; improbably low or 
high average daily caloric intake of ≤ 500 kilocalories (kcal) or ≥ 5000 kcal; missing 
information for more than one food item in the 58-item modified Harvard Food Frequency 
Questionnaire (FFQ) (Willett and others, 1987; Willett WC and others, 1985); missing 
information on covariates used in the analysis; missing information on vitamin E 
supplement intake; or missing information on quantity of vitamin E from supplements 
(Figure 1).
Estimation of Vitamin E Intake through Diet and Supplements
Mothers were interviewed by telephone in English or Spanish using a computer-based 
questionnaire six weeks to 24 months after the estimated date of delivery. Interviewers 
obtained information on maternal demographic characteristics, exposures (e.g., nutritional, 
behavioral, occupational) and medication use before and during pregnancy. The 
participation rate for mothers of control infants was 66% and for mothers of cases was 69%.
Maternal dietary intake was based on completion of the FFQ on which participants reported 
how often they consumed food items in the year before they became pregnant. In addition, 
study participants were asked about their intake of cereal and beverages from the three 
months before they became pregnant to delivery – specifically the name, the month of 
consumption, and the frequency. Vitamin E (alpha-tocopherol equivalents and other 
tocopherols) content of foods was based on the U.S. Department of Agriculture’s National 
Nutrient Database for Standard Reference 20 (US Department of Agriculture, 2007). 
Nutrient intakes were computed by multiplying the frequency with which each food item 
was consumed by its nutrient content for the portion size listed. For cereals, only 
consumption during the three months before pregnancy was included.
Mothers were also asked about use of a multivitamin, prenatal vitamin, or single component 
vitamin by month, from three months before pregnancy through the last month of 
pregnancy. For each product, mothers reported start and stop dates and frequency of intake. 
Trained pharmacists at the Slone Epidemiology Center at Boston University classified 
whether the specific supplement reported by each participant contained vitamin E or not, but 
not the dose. To quantify the dose in each supplement with vitamin E (n=694), we 
developed a dietary supplement database. Supplements with vitamin E were matched by 
name, to supplements with vitamin E reported by participants in the National Health and 
Nutrition Examination Survey (NHANES) Dietary Supplement Database (DSD) for the 
years 1999 – 2006 (US Department of Agriculture, 2009). Exact or near exact matches were 
found for 157 (22.7%) supplements; an additional 214 (30.8%) were probable matches 
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(supplement type and key words matched). When supplements reported in the NBDPS did 
not match with supplements from the DSD, other sources (i.e., company web sites, catalogs, 
and the Physician’s Desk Reference [PDR]) were used to determine the amount of vitamin E 
contained in the supplement. This approach yielded an additional 143 exact, near exact or 
probable matches (20.7%). All but two of the remaining supplements that could not be 
assigned a vitamin E content based on the aforementioned approaches were assigned a 
default value of vitamin E content (n=178). We established four categories of default values 
for the assumed quantity of vitamin E in the supplement based on the most frequently 
reported supplements of that type in NHANES found in the DSD (Appendix 1). We 
examined use of vitamin E containing supplements from the three months before pregnancy 
through the first two months of pregnancy (B3-P2). We first classified each mother’s use of 
supplements containing vitamin E as yes or no at any time (for any duration) during B3-P2. 
For each reported specific supplement (e.g., Brand X multivitamin), we then multiplied the 
amount of vitamin E contained in the specified supplement (as shown on the nutrition facts 
panel) by the reported number of tablets or pills consumed over the time period (B3-P2) and 
then divided by the number of tablets or pills corresponding to the specified supplement 
serving size (as shown on the nutrition facts panel). For each mother, the amount of vitamin 
E per day consumed from all specified supplements was calculated as the sum of vitamin E 
from all supplements divided by the number of days in B3-P2.
We calculated total daily vitamin E intake as the sum of vitamin E intake from supplements 
plus foods. We then adjusted total vitamin E intake for total calories using the nutrient 
residual method (Willett, 1998; Willett and others, 1997). Briefly, this approach is based on 
regressing individuals’ total daily vitamin E intakes on their total daily energy (calorie) 
intakes. The residuals from this regression model represent the difference between actual 
vitamin E intake and expected vitamin E intake based on total energy intake, or vitamin E 
intake unexplained by energy intake. The nutrient residual was then used to calculate an 
“energy-adjusted” vitamin E intake. The distribution of energy-adjusted vitamin E intake 
among the controls was then used to determine energy-adjusted vitamin E intake quartiles, 
which were used for all further analyses. The lowest quartile of intake was the referent.
Covariates of Interest
Maternal covariates selected a priori included age at delivery, race/ethnicity (non-Hispanic 
white, non-Hispanic black, Hispanic, other), education (less than high school, high school, 
more than high school), study center, and pre-pregnancy body mass index (BMI) in 
kilograms per square meter (kg/m2) [<18.5 kg/m2, 18.5–<25.0 kg/m2 (reference category), 
25.0–<30.0 kg/m2, and ≥30.0 kg/m2]. Total daily intake of fat, calories, and dietary folate 
were also calculated based on the FFQ and considered potential confounders in the analysis. 
Total daily dietary folate was expressed as dietary folate equivalents (DFE) (Standing 
Committee on the Scientific Evaluation of Dietary Reference Intakes, 1998). Smoking, 
alcohol use, and use of folic acid supplements, were all defined as any use or intake during 
the period of B3-P2.
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Among control mothers, we assessed the association of demographic and lifestyle factors, 
and intake of selected nutrients with quartiles of energy-adjusted total vitamin E intake. 
Then to estimate the risk of selected major birth defects associated with quartiles of energy-
adjusted total maternal vitamin E intake, we computed the crude and adjusted odds ratios 
(OR) and corresponding 95% confidence intervals (CI) using logistic regression. The 
multivariable model included study center, folate intake (as DFE), maternal race/ethnicity, 
age, education, pre-pregnancy body mass index, smoking, alcohol use, use of folic acid 
supplements, and total energy intake. In addition, in an attempt to replicate the results of the 
Dutch HAVEN study, we conducted an analysis of the association between any CHD and 
dietary intake of vitamin E, among vitamin E-containing supplement users.
We also conducted sensitivity analyses to explore the effect of missing data on vitamin E 
intake from supplements (Figure 1, lower left, n=2,421 cases and controls combined) under 
two extreme scenarios. In the first, we assumed that those with missing information on 
vitamin E from supplements were non-users (assigned them a value of 0 mg of vitamin E 
from supplements). In the second scenario, we assumed that these same individuals were 
users in the highest quartile, and assigned them the median for this quartile (18.49 mg/day of 
vitamin E from supplements). We also conducted a post-hoc sensitivity analysis to explore 
the impact of excluding mothers of cases and controls with a first degree family history of a 
birth defect.
All analyses use SAS version 9.2 statistical software (SAS Institute, Cary, NC).
RESULTS
After the stated exclusions, there were 4,525 controls and 8,665 isolated cases remaining 
(Figure 1). Selected characteristics of included control mothers are reported by quartile of 
energy-adjusted daily total vitamin E intake in Table 1. All differed significantly across 
quartiles of daily total vitamin E intake. For several characteristics, trends with increasing 
total vitamin E intake were suggested: increasing proportions of mothers with greater than a 
high school education, decreasing proportions of mothers who reported smoking during the 
period of B3-P2, and increasing proportions of mothers who reported using alcohol and 
vitamin supplements during the period of B3-P2. Overall 82.6% of controls reported taking 
a supplement containing vitamin E; this increased from 49.8% of individuals in the first 
quartile of energy-adjusted total intake to 98.7% of individuals in the fourth quartile intake 
(Table 1).
Total median energy-adjusted vitamin E intake was 7.79 mg, below the RDA of 15 mg/day. 
Of note, energy-adjusted intakes differed only slightly from the unadjusted intakes (energy-
adjusted mean = 13.52 mg; unadjusted mean = 13.59 mg). The daily mean (and median) 
intake of dietary folate, vitamin E from foods, and vitamin E from supplements increased 
with increasing quartiles of energy-adjusted total vitamin E intake (Table 2). Total fat and 
energy intake, however, did not increase with increasing quartiles of total vitamin E intake. 
In addition, daily vitamin E intake from supplements was substantially higher among 
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mothers in the fourth quartile of total energy-adjusted vitamin E intake (27.12 mg) 
compared with the other three quartiles (0.59–4.99 mg).
The results of multivariable models are presented in Tables 3 and 4. Considering all simple, 
isolated CHDs as a single outcome group, we observed a significant association with the 
third quartile of energy-adjusted vitamin E intake (OR 1.17; 95% CI 1.01–1.35), and an 
association of borderline significance with the second quartile of vitamin E intake (OR 1.14; 
95% CI 0.99–1.31). Among CHD sub-types, we observed additional associations with the 
grouping of left ventricular outflow tract obstruction defects (LVOTO), and its sub-type, 
coarctation of the aorta and the third quartile of vitamin E intake. There was also an 
association of borderline significance between septal defects and the second quartile of 
vitamin E intake. There was no evidence, however, of a vitamin E dose-response pattern of 
increased risk with increased quartiles of exposure for any of the CHDs under study (Table 
3).
For the analysis attempting to replicate the findings from the Dutch HAVEN study, we 
found that among supplement users, there was no association between dietary vitamin E 
intake and all simple, isolated CHDs with the exception of a protective effect in the fourth 
quartile of exposure (quartile 2: OR 0.98; 95% CI 0.86–1.11; quartile 3: OR 0.89; 95% CI 
0.78–1.02; quartile 4: OR 0.81; 95% CI 0.69–0.95).
Among isolated birth defects other than CHDs (Table 4), we observed a significant 
association between anorectal atresia and the third quartile of energy-adjusted total vitamin 
E intake (OR 1.66; 95% CI 1.01–2.72) and hypospadias and the fourth quartile of vitamin E 
intake (OR 1.42; 95% CI 1.09–1.87). Elevated, but not statistically significant associations 
were observed for esophageal atresia and small intestinal atresias and the fourth quartile of 
intake (Table 4).
The results of the two sensitivity analyses we conducted of missing data on vitamin E intake 
from supplements, indicated that the reported findings were robust to our assumptions 
regarding whether those with missing information were non-users (0 mg was used as the 
daily vitamin E intake value) or had high levels of vitamin E intake (18.49 mg was used as 
the daily vitamin E intake value) (data not shown). Our post-hoc analysis excluding study 
participants with a first degree family history of a birth defect resulted in qualitatively 
similar findings (data not shown).
DISCUSSION
Our results suggest that maternal vitamin E intake from foods and supplements is not a risk 
factor for CHDs. The few observed associations with CHDs do not exhibit an exposure-
response pattern that is consistent with increased risk of CHD with increased maternal intake 
of vitamin E. The most suggestive findings for associations with vitamin E intake were 
among birth defects other than CHDs - anorectal atresia and hypospadias. These associations 
have not been previously reported in the literature and are in need of replication. These 
results must be interpreted in light of the large number of comparisons conducted and the 
possibility that these could be sporadic, chance findings.
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The primary motivator to explore the association between vitamin E intake and selected 
birth defects in the NBDPS was the 2009 publication of data from the Dutch HAVEN study 
which reported a 60% increased odds of CHDs in the fourth quartile of dietary maternal 
exposure to vitamin E (Smedts and others, 2009). In the current analysis, we report a 19% 
increased odds of CHDs in the third quartile of exposure, and no increase in the fourth 
quartile (OR 1.03; 95% CI 0.88–1.20). The HAVEN study also reported, among the 
subgroup of vitamin E supplement users, a 9-fold and 5-fold increase in the odds of CHDs in 
the third and fourth quartiles of dietary vitamin E intake. We were unable to replicate these 
findings; among users of supplements containing vitamin E we found no association (and a 
protective effect in the fourth quartile of exposure) between dietary intake of vitamin E and 
CHDs.
The NBDPS analysis was able to improve upon two methodological limitations in the 
HAVEN study: a small case sample, which did not permit any analyses of individual CHD 
subtypes; and no quantification of the amount of vitamin E consumed in the prenatal, 
multivitamin, or single component supplements. The HAVEN study included a total of 276 
CHD cases composed of a limited number of subtypes – tetralogy of Fallot, atrioventricular 
septal defect, perimembranous ventricular septal defect, aortic valve stenosis, pulmonary 
valve stenosis, coarctation of the aorta, transposition of the great arteries, hypoplastic left 
heart syndrome and a “miscellaneous” (Smedts and others, 2009; p.417) category. The 
population included a mixture of isolated and non-isolated CHD, including 40 cases with a 
recognized genetic syndrome. In contrast, the NBDPS excluded infants with suspected 
single gene or chromosomal disorders, an important strength in analyses of possible 
associations with non-genetic risk factors. Also in the NBDPS analysis, we had over 3,000 
cases with isolated CHDs, and were able to consider possible heterogeneity of effects among 
16 CHD subtypes in addition to the grouping of all CHDs combined.
The associations observed for birth defects other than CHDs –anorectal atresia and 
hypospadias, were unexpected, and warrant further analysis and replication in other study 
populations. A recent study of nutrient intake and hypospadias in the NBDPS found no 
association with dietary intake of vitamin C, an antioxidant vitamin, but vitamin E was not 
investigated (Carmichael and others, 2012).
Because over 80% of NBDPS study participants reported use of multivitamins or prenatal 
supplements containing vitamin E, it was critical to quantify the amount of vitamin E in 
these supplements, and to incorporate this intake into our analysis in order to determine the 
potential role of total vitamin E intake. However, the strongest associations reported in the 
HAVEN study (9-fold and 5-fold increases in odds) were with vitamin E consumed from 
foods in the small group of users of supplements containing vitamin E. We did attempt to 
replicate this analysis in our data, and did not find evidence of an increase in risk of CHDs.
Our study had several limitations. First, there was possible measurement error in our 
estimation of vitamin E intake from supplements. The accuracy of our calculation of the 
vitamin E intake from reported supplements relied on maternal report of various exposure/
dose metrics, including the type and brand of supplement as well as the timing, frequency 
and duration of use. Any errors in these metrics could have led to misclassification of 
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exposure. In addition, vitamin E intake from supplements was largely (approximately 90%) 
derived from intake of multivitamins and prenatal vitamins, rather than from a single 
ingredient vitamin E supplement. This suggests that there may be other components in these 
multivitamins or prenatal vitamins that could be important to consider as potential 
confounders. To help account for this, we adjusted our analyses for use of supplements 
containing folic acid and for dietary folate.
Second, there was potential for measurement error in the estimation of vitamin E intake 
from foods. For cereals, we limited our use of the these data to the period from three months 
before pregnancy to conception in order to have this information more closely correspond 
with the FFQ data for other food items. The semi-quantitative FFQ used by the NBDPS asks 
about the intake of 58 specific food items during the year before pregnancy and there are 
limitations inherent in this mode of dietary data collection. The FFQ is limited in its ability 
to evaluate individual micronutrients and macronutrients (Willett WC and others, 1985). In 
addition, since it is shorter than the original Willett FFQ, it may be missing important foods 
which could result in lower estimates of overall calorie or specific nutrient intake (Willett 
WC and others, 1985). For vitamin E in particular, it has been observed that intake estimates 
might be low because the amounts and types of fat added during cooking are often 
unknown, or not accurately reported (Institute of Medicine Food and Nutrition Board, 2000). 
The FFQ is used with the assumption that women’s general food consumption patterns 
before pregnancy are representative of their consumption patterns during early pregnancy 
and that it can help rank individuals according to intake relative. Qualitative longitudinal 
data suggests this is a valid assumption (Devine and others, 2000). Although the NBDPS 
FFQ has not been internally validated, the use of food frequency questionnaires for dietary 
recall has been validated against one-year diet records though errors in recall are possible 
(Willett and others, 1987). However, given that dietary vitamin E intake was captured 
through several questions on the FFQ, and vitamin E is not generally considered a risk factor 
for adverse pregnancy outcomes, those errors are likely to be non-differential with respect to 
case-control status with possible attenuation of effects but unlikely to have resulted in recall 
bias by case-control status.
The third limitation is the possibility of selection bias if vitamin E intake were associated 
with fetal death earlier than 20 weeks’ gestation, or multiple co-occurring birth defects. 
Miscarriages and early fetal losses are not eligible for inclusion in the NBDPS and any 
association between an exposure and these outcomes would not be detected in the NBDPS; 
the exclusion from this analysis of cases with multiple co-occurring birth defects was made 
in order to maintain as much etiologic homogeneity as possible within outcomes.
It is noteworthy that the first three quartiles of energy-adjusted daily total vitamin E intake 
are below the RDA of 15 mg/day. Only mothers in the fourth quartile of intake are at or 
above the RDA for total daily vitamin E intake. These low values might be due to 
misreporting of either dietary intake or supplement intake as noted above. According to 
NHANES 1999–2000 and 2001–2002 data derived from participants’ 24-hour dietary 
recalls, U.S. women aged 19 years or older (up to age ≥70) consumed, on average 6.2 
mg/day of vitamin E from diet and 14.1 mg/day from supplements (Chun and others, 2010). 
The mean values for NBDPS participants were somewhat lower than these national 
Gilboa et al. Page 9













estimates, in part because individuals 50 years of age or older tend to consume at least twice 
as much vitamin E than younger Americans (Chun and others, 2010; Millen and others, 
2004).
In summary, our results provided no substantial evidence of an association between total 
daily vitamin E from foods and supplements and CHDs. The observed associations of 
vitamin E intake with other birth defects might represent chance findings, and thus warrant 
corroboration in other population-based studies.
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